<!doctype html>
<html lang="en" data-theme="light">

<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta name="color-scheme" content="light dark">
<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Inter:ital,opsz,wght@0,14..32,100..900;1,14..32,100..900&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.min.css">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.colors.min.css">
    <title>Solace-AI - Cholera Vaccination Prioritisation Evidence Report</title>
    <style>
        :root {
            --pico-font-family: 'Inter', serif;
            --sidebar-width: 280px;
        }

        h1,
        h2,
        h3,
        h4,
        h5,
        h6,
        nav {
            font-family: 'Inter', sans-serif;
        }

        details {
            margin-bottom: 1rem;
        }

        details summary {
            line-height: 1.5rem;
            font-weight: 600;
        }

        .sources-count {
            font-size: 0.875rem;
            color: var(--pico-muted-color);
            font-style: italic;
        }

        /* Top logo header - not sticky */
        body>header.top-header {
            padding: 1rem;
            border-bottom: 1px solid var(--pico-muted-border-color);
        }

        body>header.top-header .container-fluid {
            display: flex;
            align-items: center;
            gap: 1rem;
        }

        body>header.top-header img {
            height: 32px;
            width: auto;
        }

        /* Sticky navigation breadcrumb */
        nav.sticky-nav {
            position: sticky;
            top: -1px;
            z-index: 10;
            background-color: var(--pico-background-color);
            border-bottom: 1px solid var(--pico-muted-border-color);
            padding: 0.75rem 1rem;
        }

        nav.sticky-nav ul {
            list-style: none;
            padding: 0;
            margin: 0;
            display: flex;
            align-items: center;
            gap: 0.5rem;
        }

        nav.sticky-nav li {
            display: flex;
            align-items: center;
            gap: 0.5rem;
        }

        nav.sticky-nav .nav-toggle {
            display: inline-flex;
            align-items: center;
            gap: 0.5rem;
            padding: 0.25rem 0.5rem;
            background: none;
            border: none;
            color: var(--pico-color);
            cursor: pointer;
            text-decoration: none;
            font-size: 1rem;
            border-radius: var(--pico-border-radius);
            transition: background-color var(--pico-transition);
        }

        nav.sticky-nav .nav-toggle:hover {
            background-color: var(--pico-secondary-hover-background);
        }

        nav.sticky-nav .nav-toggle svg {
            width: 20px;
            height: 20px;
            stroke-width: 2;
        }

        nav.sticky-nav .separator {
            color: var(--pico-muted-color);
            font-weight: 300;
        }

        /* Layout with sidebar */
        body {
            margin: 0;
        }

        .page-container {
            display: grid;
            grid-template-columns: var(--sidebar-width) 1fr;
            min-height: calc(100vh - 73px);
        }

        /* Sidebar Navigation */
        aside#sidebar-nav {
            border-right: 1px solid var(--pico-muted-border-color);
            overflow-y: auto;
            background-color: var(--pico-background-color);
            display: flex;
            flex-direction: column;
        }

        aside#sidebar-nav nav {
            position: sticky;
            top: 0;
            background-color: var(--pico-background-color);
            padding: 1.5rem;
            flex-grow: 1;
            overflow-y: auto;
        }

        aside#sidebar-nav nav .nav-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 1.5rem;
            padding-bottom: 1rem;
            border-bottom: 1px solid var(--pico-muted-border-color);
        }

        aside#sidebar-nav nav .nav-header h2 {
            margin: 0;
            font-size: 1.25rem;
        }

        aside#sidebar-nav nav ul {
            list-style: none;
            padding: 0;
            margin: 0;
        }

        aside#sidebar-nav nav li {
            margin: 0.25rem 0;
        } */

        /* aside#sidebar-nav nav a {
            display: block;
            padding: 0.5rem 0.75rem;
            border-radius: var(--pico-border-radius);
            text-decoration: none;
            color: var(--pico-color);
            transition: background-color var(--pico-transition);
        }

        aside#sidebar-nav nav a:hover {
            background-color: var(--pico-secondary-hover-background);
        }

        aside#sidebar-nav nav a.active {
            background-color: var(--pico-primary-background);
            color: var(--pico-primary-inverse);
        }

        /* Close button (mobile only) */
        aside#sidebar-nav .close-btn {
            display: none;
            padding: 0.5rem;
            margin: 0;
            background: none;
            border: none;
            opacity: 0.7;
            transition: opacity var(--pico-transition);
            cursor: pointer;
        }

        aside#sidebar-nav .close-btn:hover {
            opacity: 1;
        }

        aside#sidebar-nav .close-btn svg {
            width: 1.25rem;
            height: 1.25rem;
            display: block;
        }

        /* Main content area */
        main.content-area {
            overflow-x: hidden;
        }

        main.content-area>.container {
            padding-top: 2rem;
            padding-bottom: 2rem;
        }

        /* Back to Top */
        #back-to-top {
            position: fixed;
            bottom: 2rem;
            right: 2rem;
            z-index: 100;
            display: none;
            border-radius: 50%;
            padding: 0;
            width: 3rem;
            height: 3rem;
            justify-content: center;
            align-items: center;
            box-shadow: 0 2px 5px rgba(0, 0, 0, 0.2);
        }

        #back-to-top svg {
            width: 1.5rem;
            height: 1.5rem;
        }

        /* Mobile styles (below 1024px) */
        @media (max-width: 1023px) {
            .page-container {
                grid-template-columns: 1fr;
            }

            aside#sidebar-nav {
                position: fixed;
                top: 0;
                left: 0;
                bottom: 0;
                width: 85%;
                max-width: 320px;
                z-index: 1000;
                transform: translateX(-100%);
                transition: transform 0.2s ease-in-out;
                box-shadow: 2px 0 10px rgba(0, 0, 0, 0.1);
            }

            aside#sidebar-nav.is-open-on-mobile {
                transform: translateX(0);
            }

            aside#sidebar-nav .close-btn {
                display: block;
            }

            aside#sidebar-nav nav .nav-header {
                display: flex;
            }

            /* Overlay when sidebar is open */
            body::before {
                content: '';
                position: fixed;
                top: 0;
                left: 0;
                right: 0;
                bottom: 0;
                background-color: rgba(0, 0, 0, 0.5);
                z-index: 999;
                opacity: 0;
                visibility: hidden;
                transition: opacity 0.2s ease-in-out, visibility 0.2s ease-in-out;
            }

            body.sidebar-open::before {
                opacity: 1;
                visibility: visible;
            }

            /* Prevent scrolling when sidebar is open */
            body.sidebar-open {
                overflow: hidden;
            }
        }

        /* Desktop: hide close button and nav header */
        @media (min-width: 1024px) {
            aside#sidebar-nav nav .nav-header {
                display: none;
            }

            nav.sticky-nav {
                display: none;
            }
        }
    </style>
</head>

<body>
    <!-- Top Logo Header (not sticky) -->
    <header class="top-header">
        <nav>
            <ul>
                <div class="container-fluid">
                    <img src="https://solaceai.org/img/solacelogo.svg" alt="Solace-AI" style="height: 60px;">
                </div>
            </ul>

            <ul>
                <li><button onclick="downloadHTML()">Download report</button></li>
            </ul>
        </nav>
    </header>

    <!-- Sticky Navigation Breadcrumb (mobile only) -->
    <nav class="sticky-nav">
        <ul>
            <li>
                <a href="#" class="nav-toggle" id="mobile-menu-toggle">
                    <svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke="currentColor">
                        <path stroke-linecap="round" stroke-linejoin="round" d="M4 6h16M4 12h16M4 18h16" />
                    </svg>
                </a>
            </li>
            <!-- <li class="separator">›</li> -->
            <li>Prioritising Cholera Vaccinations During Outbreaks</li>
        </ul>
    </nav>

    <div class="page-container">
        <!-- Sidebar Navigation -->
        <aside id="sidebar-nav">
            <nav>
                <div class="nav-header">
                    <h2>Navigation</h2>
                    <button class="close-btn" aria-label="Close menu">
                        <svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="2.5"
                            stroke="currentColor">
                            <path stroke-linecap="round" stroke-linejoin="round" d="M6 18L18 6M6 6l12 12" />
                        </svg>
                    </button>
                </div>
                <ul>
                    <li><a href="#top" class="active">Home</a></li>
                    
                <details name="Overview">
                    <summary>Overview</summary> 
                    <ul>
                        <li><a href="#about this report">About</a></li>
                        <li><a href="#why this matters">Importance</a></li>
                        <li><a href="#recommendations">Recommendations</a></li>
                </ul>
            </details>
                  
            <details name="Full Report">
            <summary>Full Report</summary>
            <ul>
                    <li><a href="#background">Background</a></li>
                    <li><a href="#targeting">Targeting Strategies</a></li>
                    <li><a href="#timing considerations">Timing Considerations</a></li>
                    <li><a href="#strategy decisions">Strategy Decisions</a></li>
                    <li><a href="#summary">Summary</a></li>
                </ul>
                </details>

                    <li><a href="#citations" class="">Evidence Sources</a></li>
                    <li><a href="#Have you considered" class="">Other Relevant Topics</a></li>
                    <li><a href="#Methods" class="">Methods</a></li>
                    <li><a href="#Figures" class="">Relevant Figures</a></li>
                </ul>
            </nav>
        </aside>

        <!-- Main Content Area -->
        <main class="content-area" id="top">
            <div class="container">

                <h2>Prioritising Cholera Vaccinations During Outbreaks</h2>

                <hr>
                <em>World Health Organization - Impacts of Climate Change on Human Health:</em>
                <p>
                 <div style="
                    display: inline-block;
                    background-color: #38bdf8;
                    color: white;
                    padding: 16px 28px;
                    border-radius: 12px;
                    font-size: 1rem;
                    font-weight: 600;
                    margin: 8px;
                        ">Water quality impacts</div>
                        </p>
                <hr>

                <p><h4><u>Overview</u></h4></p>

                 <article id="about this report">
                    <h3>About this report</h3>
                    <p>This report synthesises evidence on prioritsing vaccinations during Cholera outbreaks. We searched Semantic Scholar, PubMed, WHO policy reports, and CDC policy 
                        reports on <strong>9 February 2026</strong>.</p>
                    <p>We included <strong>26 evidence sources</strong> comprising systematic reviews, cohort studies, cross-sectional surveys, and policy evaluations.</p>
                </article>

                <article id="why this matters">
                    <h3>Why this matters</h3>
                    <ul>
                        <li>Global cholera cases are increasing rapidly which has impacted on global supply of vaccinations</li>
                        <li>The global supply crisis has fundamentally shaped vaccination prioritisation</li>
                        <li>Cholera vaccination during outbreaks should target high-risk populations first, focus on areas with active transmission, and use a systematic approach that considers disease spread patterns and population vulnerability</li>
                    </ul>
                </article>

                <article id="evidence">
                <h3>Evidence-based recommendations</h3>
                <table>
                    <thead>
                        <tr>
                            <th>Evidence strength</th>
                            <th>Intervention / Recommendation</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td rowspan="4" class="pico-color-lime-300"><strong>✓ Strong evidence</strong></td>
                            <td>Pre-emptive vaccination strategies</td>
                        </tr>
                        <tr>
                            <td>Geographic and population-level targeting</td>
                        </tr>
                        <tr>
                            <td>Single-dose approach for reactive strategies</td>
                        </tr>
                        <tr>
                            <td>Ring vaccination within 100m of index case</td>
                        </tr>

                        <tr>
                            <td class="pico-color-pumpkin-300"   ><strong>◐ Weak evidence</strong></td>
                            <td class="pico-color-zinc-200">No interventions identified</td>
                        </tr>
                        <tr>
                            <td class="pico-color-slate-500" ><strong>? Uncertain</strong></td>
                            <td class="pico-color-zinc-200">No interventions identified</td>
                        </tr>
                        <tr>
                            <td class="pico-color-red-550"><strong>✗ Likely harmful</strong></td>
                            <td class="pico-color-zinc-200">No interventions identified</td>
                        </tr>
                    </tbody>
                </table>
                </article>
                
                <hr>

                <p><h4><u>Full Report</u></h4>

                <article id="background">
                    <h3>Background</h3>
                    <p class="sources-count">(6 sources)</p>

                    <details>
                        <summary>
                        Cholera remains a major global health threat with an estimated 2.9 million cases and 95,000 deaths annually, primarily affecting Sub-Saharan Africa and regions 
                        with poor sanitation infrastructure. Cholera vaccination during outbreaks should target high-risk populations first, focus on areas with active transmission, and 
                        use a systematic approach that considers disease spread patterns and population vulnerability. 
                        </summary>

                        <p>Despite being preventable and treatable, cholera continues to impose a substantial global health burden, with estimates indicating approximately 2.9 million 
                            cases and up to 95,000 deaths occurring annually worldwide
                                <a href="https://www.semanticscholar.org/reader/32b902c14d78ff29a3c1bf44ae05496bae8be783">(Ali et al, 2015).</a> 
                            The global distribution of cholera burden is highly unequal, with approximately 1.3 billion people living at risk in endemic countries, and Sub-Saharan 
                            Africa bearing the majority of this burden 
                                <a href="https://www.semanticscholar.org/reader/32b902c14d78ff29a3c1bf44ae05496bae8be783">(Ali et al, 2015).</a> 
                            Recent years have witnessed some of the most severe outbreaks in recorded history, with 2017 marking a particularly devastating year due to major outbreaks 
                            in Yemen, the Democratic Republic of Congo, Nigeria, Somalia and South Sudan 
                                <a href="https://www.semanticscholar.org/reader/7ca37d2da3cb6b20960e8fa00774261e05f4521a">(White et al, 2022).</a>
                            </p>

                        <p>Global cholera cases more than doubled from 2021, with over 600,000 cases and roughly 7,600 deaths reported in 2024 alone across 33 countries 
                                <a href="https://www.who.int/news/item/12-09-2025-cholera-kills-more-people-for-second-consecutive-year-while-prevention-and-treatment-available">(WHO, 2025).</a>
                            In October 2024, the global stockpile of oral cholera vaccine (OCV) ran completely dry 
                                <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11932455/">(Houston & Houston, 2025).</a>
                            Supply has since recovered substantially. Annual production reached approximately 70 million doses in 2025, up from 35 million in 2022 
                                <a href="https://www.who.int/news/item/04-02-2026-preventive-cholera-vaccination-resumes-as-global-supply-reaches-critical-milestone">(WHO, 2026).</a>
                        </p>

                        <p> OCV in outbreaks is most effective when it is geographically targeted to where transmission risk is highest (e.g., displaced populations, dense informal settlements, 
                            flood-affected communities) and delivered fast enough to reduce onward spread, while not diverting resources from the core pillars of cholera control: case management 
                            (rapid rehydration), safe water/sanitation, and risk communication 
                                <a href="https://list.essentialmeds.org/files/decisions/bTLGqWYSe4O7IsZrlePTHFRdO1nS8qRHkHoqaiuQ.pdf">(WHO, 2017).</a>
                        </p>
                    </details>
                </article>

                <article id="targeting">
                    <h3>Geographic and Population-Level Targeting Strategies</h3>
                    <p class="sources-count">(10 sources)</p>

                    <details>
                        <summary>Geographic targeting should focus on areas with high attack rates and active transmission, using surveillance data to map hotspots. Population-level 
                            targeting should prioritise children aged 1-14 years, the elderly, pregnant women and displaced communities as they are most at-risk. Innovative ring vaccination 
                            approaches targeting households within 70-100 metres of cases can achieve high effectiveness. </summary>

                        <p>Effective prioritisation rests on 1. geographic targeting of hotspots, and 2. population-level risk stratification within those hotspots. Geographic targeting 
                            strategies rely heavily on surveillance data to identify high-risk areas for vaccination campaigns. </p>

                        <p>Population-level prioritisation, when vaccine supply is constrained, follows a risk hierarchy informed by age, health status, and living conditions. The highest priority groups include:
                            <ul>
                                <li><strong>Children aged 1-5 years</strong>,
                                 who face the highest cholera mortality rates globally and for whom single-dose protection wanes most rapidly, with vaccine effectiveness dropping to roughly 33% by year three 
                                versus sustained protection in older individuals 
                                    <a href="https://www.sciencedirect.com/science/article/pii/S1473309923007429">(Malembaka et al, 2024).</a>
                                However, limiting vaccination to children aged 1-5 years can be less effectives because vaccine efficiency is lower among young children, therefore evidence suggests the optimal 
                                strategy is to prioritise older children (5-14 years), irrespective of setting and level of vaccination
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/35442958/">(Leung et al, 2021).</a>
                                </li>
                                <li><strong>Displaced populations in refugee and IDP camps</strong>,
                                    where attack rates of 1-5% are common and WASH infrastructure is often lacking or absent
                                        <a href="https://epidemics.ifrc.org/manager/disease/cholera">(IFRC, 2025).</a>
                                </li>
                                <li><strong>Urban slum dwellers</strong>,
                                    particularly in peri-urban areas lacking sanitation infrastructure, where the WHO identifies <em>typical at-risk areas</em>
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/19762952/">(Talavera & Pérez, 2009).</a>
                                </li>
                                <li><strong>Women</strong> are more at risk than men. For example, women in the Somali Region of Ethiopia were more than four times as likely to die from the Cholera epidemic of 2017 compared to men
                                    <a href="https://link.springer.com/article/10.1186/s12889-026-26660-6">(Hassen & Warfa, 2026)</a></li>
                                <li><strong>Pregnant women and immunocompromised individuals</strong> (including those with HIV), for whom OCV is safe and the risk-benefit ration strongly favours vaccination
                                    <a href="https://www.choleraoutbreak.org/book-page/section-9-oral-cholera-vaccine.html">(Global Task Force on Cholera Control, 2026).</a>
                                </li>
                                <li><strong>Elderly populations over 65 years</strong> who exhibit case fatality rates 5-10 times higher than younger adults in historical data.
                                </li>
                            </ul>
                        </p>

                        <p>Ring vaccination strategies offer a promising targeted approach, particularly in urban settings. Since Cholera cases tend to cluster in time and place, particularly among household 
                            contacts of a cholera case, ring vaccination around cases could be considered 
                                <a href="https://www.semanticscholar.org/paper/Licensed-and-Recommended-Inactivated-Oral-From-to-Deen-Clemens/53644b97a9dcea99928e4126a3514796739310c4">(Deen & Clemens, 2021)</a>
                                <a href="https://www.semanticscholar.org/reader/fe2d5997240934146fc7b25240cc5c3423745423">(Sugimoto et al, 2014).</a>
                            Evidence shows that high-level protection can be achieved for those living close to cholera cases 
                                <a href="https://www.semanticscholar.org/paper/Licensed-and-Recommended-Inactivated-Oral-From-to-Deen-Clemens/53644b97a9dcea99928e4126a3514796739310c4">(Deen & Clemens, 2021)</a>
                                <a href="https://www.semanticscholar.org/reader/f59f0fd447c99847eb2e166f6337705891d5f8b9">(Ali et al, 2016).</a>
                            Modelling studies demonstrate vaccinating people within 100m around index case households and improving their water source early in epidemics could reduce the number of cases by 82% 
                            compared to uncontrolled epidemics 
                                <a href="https://www.semanticscholar.org/paper/Licensed-and-Recommended-Inactivated-Oral-From-to-Deen-Clemens/53644b97a9dcea99928e4126a3514796739310c4">(Deen & Clemens, 2021)</a>
                                <a href="https://www.semanticscholar.org/reader/292e16493d301c4edb56398d6c4dd7e5954d1aa2">(Finger et al, 2018)</a>
                                <a href="https://www.semanticscholar.org/reader/ef7b82fdb2c71e4ac10363705fd40cbfdfebb373">(von Seidlein & Deen, 2018)</a>
                        </p>
                        </details>
                </article>
        
                <article id="timing considerations">
                    <h3>Timing Considerations and Campaign Intervention</h3>
                    <p class="sources-count">(6 sources)</p>

                    <details>
                        <summary>Speed is critical as vaccinating early during outbreaks can prevent up to 40% of cases and reduce mortality, while delayed responses still provide benefits in prolonged outbreaks. 
                            Pre-emptive vaccination before peak seasons or in high-risk periods offers best outcomes, but reactive campaigns remain valuable if implemented within the first few months.
                        </summary>

                        <p>The timing of cholera vaccination campaigns is crucial for maximising their impact, with rapid deployment being the most important factor for success. Delayed response can still provide 
                            substantial benefits, particularly in prolonged outbreaks. If circumstances prevent a rapid response there are good reasons to roll out cholera mass vaccination campaigns well into the outbreak 
                                <a href="https://www.semanticscholar.org/reader/4546f0fdab693184c32fca9a46d4e80e2f1a29f5">(Reyburn et al, 2011).</a>
                            The key threshold appears to be implementation within the first few months, as reactive vaccination campaigns can be implemented within the first few months of an epidemic to maintain effectiveness 
                                <a href="https://royalsocietypublishing.org/rsif/article/12/111/20150703/35616/Optimal-allocation-of-the-limited-oral-cholera">(Morre & Lessler, 2015).</a>
                        </p>

                        <p>Pre-emptive vaccination strategies offer the greatest potential impact by preventing outbreaks before they begin. Pre-emptive vaccination should be considered by local health authorities to help prevent 
                            potential outbreaks or the spread of current outbreaks to new areas 
                                <a href="https://www.semanticscholar.org/reader/259145346824ee885f8fae0bbbdb57fa95eb6705">(López-Gigosos et al, 2011).</a>
                            This approach is particularly valuable when strategic timing of vaccination programmes, ideally preceding the expected cholera peak seasons, could significantly enhance control outcomes 
                                <a href="https://www.semanticscholar.org/reader/90016b914d9587ea8efd90f5376239feaa4e5352">(Gyamfi, 2025).</a>
                            In conflict settings, integrating vaccination strategies in emergency responses plans, ideally before the projected outbreak peaks, particularly when risk factors such as water shortage and displacement 
                            are prominent, can prevent large-scale transmission 
                                <a href="https://pubmed.ncbi.nlm.nih.gov/40727031/">(Azhary et al, 2025).</a>
                        </p>

                        <p>The choice between pre-emptive and reactive vaccination depends on several factors. The optimal allocation of vaccine doses between endemic and epidemic settings depends on five factors 
                                <a href="https://royalsocietypublishing.org/rsif/article/12/111/20150703/35616/Optimal-allocation-of-the-limited-oral-cholera">(Moore et al, 2015):</a>

                                <ol>
                                    <li>The expected size of the epidemic</li>
                                    <li>The amount of time it will take to begin the reactive vaccinationcampaign in the epidemic setting</li>
                                    <li>The estimated size of the population at risk of infection in the epidemic setting</li>
                                    <li>The number of doses remaining in the stockpile</li>
                                    <li>The time horizon over which we compare performance</li>
                                </ol>
                        </p>

                        <p>Implementation flexibility is essential for campaign management. Both pre-emptive and reactive approaches should cover as many people as possible and should be conducted as quickly as possible to 
                        maximise their effectiveness 
                            <a href="https://www.semanticscholar.org/reader/259145346824ee885f8fae0bbbdb57fa95eb6705">(López-Gigosos et al, 2011).</a>
                        </p>
                </details>       
                </article>

                <article id="strategy decisions">
                    <h3>Vaccination Strategy Decisions</h3>
                    <p class="sources-count">(5 sources)</p>

                    <details>
                        <summary>During cholera outbreaks with limited vaccination supplies, single-dose strategies are recommended to maximise population coverage and provide rapid protection. The choice between single-dose 
                            and two-dose regimens depends on outbreak timing, population exposure history, and logistical constraints, with single-dose being preferred for late-stage outbreaks or vaccine-scarce situations.
                        </summary>

                        <p>
                            The fundamental decision in cholera vaccination during outbreaks is choosing between single-dose and two-dose strategies, with single-dose approaches increasingly recommended when vaccine supplies 
                            are limited. In outbreaks, a single-dose strategy may be considered for short-term protection 
                                <a href="https://pubmed.ncbi.nlm.nih.gov/31266672/">(Sekhar & Kang, 2020).</a>
                            This approach is particularly valuable because healthcare organisations recommend adopting a single-dose strategy instead of a two-dose strategy. Though the efficacy of a single-dose is lower, it 
                            provides coverage and rapidly protects as many of the at-risk population as possible, which may avert more cases and deaths when vaccine supplies are limited 
                                <a href="https://link.springer.com/article/10.1007/s40815-022-01388-8">(Qasem et al, 2022).</a>
                        </p>

                        <p>The timing of vaccination initiation significantly influences the optimal dosing strategy. For reactive vaccination, a trade-off between timing and effectiveness was revealed. A single dose approach may 
                            be nearly or more effective than vaccinating fewer individuals with a complete two-dose programme assuming conservative vaccine effectiveness estimates 
                                <a href="https://link.springer.com/article/10.1186/s12879-019-4688-6">(Havumaki et al, 2019).</a>
                            The populations previous cholera exposure history should also inform dosing decisions. When OCVs are used for the control of an outbreak in a known high-endemicity hotspot and/or late in an outbreak, 
                            it may be practical and cost-effective to use a single-dose OCV in order to maximise the number of individuals reached with a first dose
                                <a href="https://www.semanticscholar.org/reader/9adcb57c936448088f7846531bd6569ecab2f338">(Holmgren, 2021).</a>
                        </p>

                        <p>Logistical constraints often favour single-dose approaches during outbreak responses. This consideration is particularly important if vaccination occurs later in the outbreak, where rapid protection is 
                            needed. Given current global constraints, including global OCV shortages, there is an urgent need for each country reporting cholera outbreaks to be strategic on how vaccines are to be deployed 
                                <a href="https://www.semanticscholar.org/reader/5be56808a1b4c19c7981c0ab42f73086639bd7e2">(Chisenga et al, 2024).</a>
                        </p>

                    </details>
                </article>

                <article id="summary">
                    <h3>Summary</h3>
                    <p class="sources-count">(System Summary)</p>
                    <p>Cholera remains a major and growing global health threat. The OCV supply crisis has made strategic prioritisation of vaccination during outbreaks more important than ever. Theres is strong evidence supporting 
                        several strategies to maximise impact. These include pre-emptive vaccination, geographic and population-level targeting, ring vaccinations, and single-dose strategies during reactive outbreaks. Timing is critical. 
                        Reactive campaigns implemented within the first few months of an outbreak can still prevent a substantial proportion of cases and deaths. Delayed campaigns remain valuable in prolonged outbreaks, but speed of deployment 
                        is consistently the most important determinant of impact. Vaccination should be viewed as complementary to the core pillars of cholera control: rapid case management and rehydration, safe water and sanitation, and risk communication.
                    </p>
                </article>

                 <article id="have you considered">
                    <h3>Have you also considered…</h3>
                    <ul>
                        <li>What factors influence uptake of vaccinations?</li>
                        <li>How much is climate change contributing to the frequency of outbreaks of cholera?</li>
                        <li>What community-based early warning systems have proven effective in reducing health emergencies such as cholera and vector-borne diseases?</li>
                        </li>
                    </ul>
                </article>

                <article id="citations">
                    <h3>26 Unique Sources Cited in This Report</h3>

                    <details>
                        <summary>View all citations</summary>

                        <ol>
                            <li>Ali, M., Nelson, A.R., Lopez, A.L. & Sack, D.A. (2015).
                                <strong>Updated Global Burden of Cholera in endemic countries.</strong>
                                <em>PLOS Neglected Tropical Diseases.</em>
                                <a href="https://doi.org/10.1371/journal.pntd.0003832">https://doi.org/10.1371/journal.pntd.0003832</a>
                            </li>

                            <li>White, S., Mutula, A.C., Buroko, M.M., Heath, T., Mazimwe, F.K., Blanchet, K., Curtis, V. & Dreibelbis, R. (2022).
                                <strong>How does handwashing behaviour change in response to a cholera outbreak? A qualitative case study in the Democratic Republic of the Congo.</strong>
                                <em>PLOS ONE</em>
                                <a href="https://doi.org/10.1371/journal.pone.0266849">https://doi.org/10.1371/journal.pone.0266849</a>
                            </li>

                            <li>World Health Organization (2025).
                                <strong><em>Cholera kills more people for second consecutive year, while prevention and treatment available.</em></strong>
                                <a href="https://www.who.int/news/item/12-09-2025-cholera-kills-more-people-for-second-consecutive-year-while-prevention-and-treatment-available">https://www.who.int/news/item/12-09-2025-cholera-kills-more-people-for-second-consecutive-year-while-prevention-and-treatment-available</a>
                            </li>

                            <li>Houston, A.R. & Houston, S. (2025).
                                <strong>Cholera vaccines for the rich, cholera for the poor: While the global cholera vaccine stockpile runs dry, a booming market for high-income 
                                    countries exemplifies the chasm between commercial interests and global health needs.</strong>
                                <em>PLOS Global Public Health</em>
                                <a href="https://doi.org/10.1371/journal.pgph.0004359">https://doi.org/10.1371/journal.pgph.0004359</a>
                            </li>

                            <li>World Health Organization. (2026).
                                <strong><em>Preventive cholera vaccination resumes as global supply reaches critical milestone</em></strong>
                                <a href="https://www.who.int/news/item/04-02-2026-preventive-cholera-vaccination-resumes-as-global-supply-reaches-critical-milestone">https://www.who.int/news/item/04-02-2026-preventive-cholera-vaccination-resumes-as-global-supply-reaches-critical-milestone</a>
                            </li>

                            <li>World Health Organization. (2017). 
                                <strong>Cholera vaccines: WHO position paper – August 2017</strong>
                                <a href="https://list.essentialmeds.org/files/decisions/bTLGqWYSe4O7IsZrlePTHFRdO1nS8qRHkHoqaiuQ.pdf">https://list.essentialmeds.org/files/decisions/bTLGqWYSe4O7IsZrlePTHFRdO1nS8qRHkHoqaiuQ.pdf</a>
                            </li>

                            <li>Malembaka, E.B., Bugeme, P.M., Hutchins, C., Xu, H., Hulse, J.D., Demby, M.N., Gallandat, K., Saidi, J.M., Rumedeka, B.B., Itongwa, M., Tshiwedi-Tsilabia, E., Kitoga, F., Bodisa-Matamu, T., Kavunga-Membo, H., Bengehya, J., Kulondwa, J-C., Debes, A.K., Taty, N., Lee, E.C., Lunguya, O. & Azman, A.S. (2024).
                                <strong>Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control study.</strong>
                                <em>The Lancet: Infectious Diseases.</em>
                                <a href="https://doi.org/10.1016/S1473-3099(23)00742-9">https://doi.org/10.1016/S1473-3099(23)00742-9</a>
                            </li>

                            <li>Leung, T., Eaton, J. & Matrajt, L. (2022).
                                <strong>Optimizing one-dose and two-dose cholera vaccine allocation in outbreak settings: A modeling study.</strong>
                                <em>PLOS Neglected Tropical Diseases.</em>
                                <a href="https://doi.org/10.1371/journal.pntd.0010358">https://doi.org/10.1371/journal.pntd.0010358</a>
                            </li>

                            <li>International Federation of Red Cross. (2025).
                                <strong><em>Cholera.</em></strong>
                                <a href="https://epidemics.ifrc.org/manager/disease/cholera">https://epidemics.ifrc.org/manager/disease/cholera</a>
                            </li>

                            <li>Talavera, A. & Pérez, E.M. (2009).
                                <strong>Is cholera disease associated with poverty?</strong>
                                <em>Journal of Infection in Developing Countries.</em>
                                <a href="https://doi.org/10.3855/jidc.410">https://doi.org/10.3855/jidc.410</a>
                            </li>

                            <li>Hassen, M.A. & Warfa, N. (2026). 
                                <strong>Epidemiological analysis of a cholera outbreak in pastoral communities in the Somali region of Ethiopia.</strong>    
                                <a href="https://doi.org/10.1186/s12889-026-26660-6">https://doi.org/10.1186/s12889-026-26660-6</a>
                            </li>

                            <li>Global Task Force on Cholera Control. (2026).
                                <strong><em>Section 9: Cholera Vaccine.</em></strong>
                                <a href="https://www.choleraoutbreak.org/book-page/section-9-oral-cholera-vaccine.html">https://www.choleraoutbreak.org/book-page/section-9-oral-cholera-vaccine.html</a>
                            </li>

                            <li>Deen, J. & Clemens, J. (2021).
                                <strong>Licensed and Recommended Inactivated Oral CholeraVaccines: From Development to Innovative Deployment.</strong>
                                <em>Tropical Medicine and Infectious Disease.</em>
                                <a href="https://doi.org/10.3390/tropicalmed6010032">https://doi.org/10.3390/tropicalmed6010032</a>
                            </li>

                            <li>Sugimoto, J.D., Koepke, A.A., Kenah, E.E., Holloran, M.E., Chowdhury, F., Khan, A.I., LaRocque, R.C., Yang, Y., Ryan, E.T., Qadri, F., Calderwood, S.B., Harris, J.B. & Longini Jr, I.R. (2014).
                                <strong>Household Transmission of Vibrio cholerae in Bangladesh.</strong>
                                <em>PLOS Neglected Tropical Diseases.</em>
                                <a href="https://doi.org/10.1371/journal.pntd.0003314">https://doi.org/10.1371/journal.pntd.0003314</a>
                            </li>

                            <li>Finger, F., Bertuzzo, E., Luquero, F.J., Naibei, N., Touré, B., Allan, M., Porten, K., Lessler, J., Rinaldo, A. & Azman, A.S. (2018).
                                <strong>The potential impact of case-area targeted interventions in response to cholera outbreaks: A modeling study.</strong>
                                <em>PLOS Medicine.</em>
                                <a href="The potential impact of case-area targeted interventions in response to cholera outbreaks: A modeling study">The potential impact of case-area targeted interventions in response to cholera outbreaks: A modeling study</a>
                            </li>

                            <li>von Seidlein, L. & Deen, J.L.  (2018).
                                <strong>Preventing cholera outbreaks through early targeted interventions.</strong>
                                <em>PLOS Medicine.</em>
                                <a href="https://doi.org/10.1371/journal.pmed.1002510">https://doi.org/10.1371/journal.pmed.1002510</a>
                            </li>

                            <li>Reyburn, R., Deen, D.L, Grais, R.F., Bhattacharya, S.K., Sur, D., Lopez, A.L., Jiddawi, M.S., Clemens, J.D. & von Seidlein, L. (2011).
                                <strong>The Case for Reactive Mass Oral Cholera Vaccinations</strong>
                                <em>PLOS Neglected Tropical Diseases.</em>
                                <a href="https://doi.org/10.1371/journal.pntd.0000952">https://doi.org/10.1371/journal.pntd.0000952</a>
                            </li>

                            <li>Moore, S.M. & Lessler, J. (2015).
                                <strong>Optimal allocation of the limited oral cholera vaccine supply between endemic and epidemic settings.</strong>
                                <em>Journal of The Royal Society Interface.</em>
                                <a href="https://doi.org/10.1098/rsif.2015.0703">https://doi.org/10.1098/rsif.2015.0703</a>
                            </li>

                            <li>López-Gigosos, R.M., Plaza, E., Díez-Díaz, R.M. & Calvo, M.J. (2011).
                                <strong>Vaccination Strategies to Combat an Infectious Globe: Oral Cholera Vaccines.</strong>
                                <em>Journal of Global Infectious Diseases.</em>
                                <a href="https://doi.org/10.4103/0974-777X.77297">https://doi.org/10.4103/0974-777X.77297</a>
                            </li>

                            <li>Gyamfi, E.H. (2025).
                                <strong>Modeling Cholera Dynamics with Vaccination as the Control Strategy and Seasonal-forcing Transmission.</strong>
                                <a href="https://arxiv.org/abs/2507.09947">https://arxiv.org/abs/2507.09947</a>
                            </li>

                            <li>Azhary, A., Hajhamed, N.M., Altyip, A.N., Elamin, E., Ali, E.T.O., Ahmed, A. & Siddig, E.E. (2025).
                                <strong>Resurgence of cholera in Kosti City, Sudan: impact of armed conflict and water supply disruption.</strong>
                                <em>IJID Regions.</em>
                                <a href="https://doi.org/10.1016/j.ijregi.2025.100700">https://doi.org/10.1016/j.ijregi.2025.100700</a>
                            </li>

                            <li>Sekhar, A. & Kang, G. (2020).
                                <strong>Pathways to a policy for cholera control in India.</strong>
                                <em>Vaccine.</em>
                                <a href="https://doi.org/10.1016/j.vaccine.2019.06.036">https://doi.org/10.1016/j.vaccine.2019.06.036</a>
                            </li>

                            <li>Qasem, A.G., Lam, S.S. & Aqlan, F. (2022).
                                <strong>A Fuzzy-Based Approach for Cholera Risk Assessment and Vaccine Allocation.</strong>
                                <em>International Journal of Fuzzy Systems.</em>
                                <a href="https://doi.org/10.1007/s40815-022-01388-8">https://doi.org/10.1007/s40815-022-01388-8</a>
                            </li>

                            <li>Havumaki, J., Meza, R.. Phares, C.R., Date, K. & Eisenberg, M.C. (2019).
                                <strong>Comparing alternative cholera vaccination strategies in Maela refugee camp: using a transmission model in public health practice.</strong>
                                <em>BMC Infectious Diseases.</em>
                                <a href="https://doi.org/10.1186/s12879-019-4688-6">https://doi.org/10.1186/s12879-019-4688-6</a>
                            </li>

                            <li>Holmgren, J. (2021).
                                <strong>An Update on Cholera Immunity and Current and Future Cholera Vaccines.</strong>
                                <em>Tropical Medicine and Infectious Diseases.</em>
                                <a href="https://doi.org/10.3390/tropicalmed6020064">https://doi.org/10.3390/tropicalmed6020064</a>
                            </li>

                            <li>Chisenga, C.C., Phiri, B., Ng'ombe, H., Muchimba, M., Musukuma-Chifulo, K., Silwamba, S., Laban, N.M., Luchen, C., Liswaniso, F., Chibesa, K., Mubanga, C., Mwape, K., Simuyandi, M., Cunningham, A.F., Sack, D. & Bosomprah, S. (2024).
                                <strong>Seroconversion and Kinetics of Vibriocidal Antibodies during the First 90 Days of Re-Vaccination with Oral Cholera Vaccine in an Endemic Population.</strong>
                                <em>Vaccines.</em>
                                <a href="https://doi.org/10.3390/vaccines12040390">https://doi.org/10.3390/vaccines12040390</a>
                            </li>

                        </ol>
                    </details>
                </article>  

               <hr>

                <article id="Methods">
                    <h3>Methods</h3>
                    <p><em>Brief overview of the steps undertaken to produce the output – link to Solace-AI website
                            which will include a more detailed technical overview of the methods of the system.</em></p>
                </article>

                <article id="Figures">
                    <h3>Related Figures from Source Materials</h3>
                    <p><em>Bank of relevant images/figures from source material used in report - e.g., heat map of affected areas</em></p>
                </article>

                <footer>
                    <p><small>Evidence report generated by Solace-AI | <a href="https://solaceai.org">Find out
                                more</a></small></p>
                </footer>
            </div>
        </main>
    </div>

    <button id="back-to-top" onclick="window.scrollTo({top: 0, behavior: 'smooth'})" aria-label="Back to top">
        <svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="2.5"
            stroke="currentColor">
            <path stroke-linecap="round" stroke-linejoin="round" d="M4.5 15.75l7.5-7.5 7.5 7.5" />
        </svg>
    </button>

    <script>
        // Back to top button
        const backToTopButton = document.getElementById('back-to-top');

        window.addEventListener('scroll', () => {
            if (window.scrollY > 500) {
                backToTopButton.style.display = 'flex';
            } else {
                backToTopButton.style.display = 'none';
            }
        });

        // Sidebar toggle functionality
        const mobileMenuToggle = document.getElementById('mobile-menu-toggle');
        const sidebar = document.getElementById('sidebar-nav');
        const closeBtn = sidebar.querySelector('.nav-header .close-btn');
        const body = document.body;

        function openSidebar() {
            sidebar.classList.add('is-open-on-mobile');
            body.classList.add('sidebar-open');
        }

        function closeSidebar() {
            sidebar.classList.remove('is-open-on-mobile');
            body.classList.remove('sidebar-open');
        }

        if (mobileMenuToggle) {
            mobileMenuToggle.addEventListener('click', (e) => {
                e.preventDefault();
                openSidebar();
            });
        }

        closeBtn.addEventListener('click', closeSidebar);

        // Close sidebar when clicking overlay (mobile)
        body.addEventListener('click', (e) => {
            if (body.classList.contains('sidebar-open') &&
                !sidebar.contains(e.target) &&
                !mobileMenuToggle.contains(e.target)) {
                closeSidebar();
            }
        });

        // Close sidebar when clicking a link (mobile)
        const sidebarLinks = sidebar.querySelectorAll('a');
        sidebarLinks.forEach(link => {
            link.addEventListener('click', () => {
                if (window.innerWidth < 1024) {
                    closeSidebar();
                }
            });
        });

        // Highlight active section in sidebar
        function updateActiveLink() {
            const sections = ['top', 'recommendations', 'evidence', 'background', 'citations'];
            let currentSection = 'top';

            sections.forEach(sectionId => {
                const section = document.getElementById(sectionId);
                if (section) {
                    const rect = section.getBoundingClientRect();
                    if (rect.top <= 100 && rect.bottom >= 100) {
                        currentSection = sectionId;
                    }
                }
            });

            sidebarLinks.forEach(link => {
                const href = link.getAttribute('href');
                if (href === '#' + currentSection) {
                    link.classList.add('active');
                } else {
                    link.classList.remove('active');
                }
            });
        }

        window.addEventListener('scroll', updateActiveLink);

        function downloadHTML() {
            // Get the entire HTML of the page
            const htmlContent = document.documentElement.outerHTML;

            // Create a Blob with the HTML content
            const blob = new Blob([htmlContent], { type: 'text/html' });

            // Create a temporary download link
            const link = document.createElement('a');
            link.href = URL.createObjectURL(blob);
            link.download = 'solaceai_evidence_report.html';

            // Trigger the download
            link.click();

            // Clean up
            URL.revokeObjectURL(link.href);
        }
    </script>
</body>

</html>
